Lu F - Search Results

1

Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study).

Aihara M, Lu F, Kawata H, Tanaka Y, Yamamura K, Odani-Kawabata N, Shams NK. Aihara M, et al. Among authors: lu f. J Ocul Pharmacol Ther. 2019 Dec;35(10):542-550. doi: 10.1089/jop.2019.0044. Epub 2019 Nov 1. J Ocul Pharmacol Ther. 2019. PMID: 31674861 Free PMC article. Clinical Trial.

2

Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension.

Aihara M, Lu F, Kawata H, Iwata A, Liu K, Odani-Kawabata N, Shams NK. Aihara M, et al. Among authors: lu f. J Glaucoma. 2019 May;28(5):375-385. doi: 10.1097/IJG.0000000000001221. J Glaucoma. 2019. PMID: 30839416 Clinical Trial.

3

Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study.

Aihara M, Lu F, Kawata H, Iwata A, Odani-Kawabata N, Shams NK. Aihara M, et al. Among authors: lu f. Am J Ophthalmol. 2020 Dec;220:53-63. doi: 10.1016/j.ajo.2020.06.003. Epub 2020 Jun 10. Am J Ophthalmol. 2020. PMID: 32533949 Free article. Clinical Trial.

4

Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study.

Aihara M, Ropo A, Lu F, Kawata H, Iwata A, Odani-Kawabata N, Shams N. Aihara M, et al. Among authors: lu f. Jpn J Ophthalmol. 2020 Jul;64(4):398-406. doi: 10.1007/s10384-020-00748-x. Epub 2020 Jun 22. Jpn J Ophthalmol. 2020. PMID: 32572719 Clinical Trial.

5

A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6).

Olander KW, Sato MA, Abrams MA, Jerkins GW, Lu F, Dinh P, Odani-Kawabata N, Chabi A, Shams NK. Olander KW, et al. Among authors: lu f. J Glaucoma. 2021 Jun 1;30(6):473-480. doi: 10.1097/IJG.0000000000001836. J Glaucoma. 2021. PMID: 33813559 Free PMC article. Clinical Trial.

6

Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study.

Aihara M, Lu F, Kawata H, Iwata A, Odani-Kawabata N. Aihara M, et al. Among authors: lu f. Jpn J Ophthalmol. 2021 Nov;65(6):810-819. doi: 10.1007/s10384-021-00868-y. Epub 2021 Sep 8. Jpn J Ophthalmol. 2021. PMID: 34495425 Clinical Trial.

7

Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study.

Wirta DL, Kuwayama Y, Lu F, Shao H, Odani-Kawabata N. Wirta DL, et al. Among authors: lu f. J Ocul Pharmacol Ther. 2022 Apr;38(3):240-251. doi: 10.1089/jop.2021.0077. Epub 2022 Feb 15. J Ocul Pharmacol Ther. 2022. PMID: 35167779 Free PMC article. Clinical Trial.

8

FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma.

Sharif NA, Odani-Kawabata N, Lu F, Pinchuk L. Sharif NA, et al. Among authors: lu f. Exp Eye Res. 2023 Apr;229:109415. doi: 10.1016/j.exer.2023.109415. Epub 2023 Feb 18. Exp Eye Res. 2023. PMID: 36803996 Review.

9

Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3).

Bacharach J, Brubaker JW, Evans DG, Lu F, Odani-Kawabata N, Yamabe T, Wirta DL. Bacharach J, et al. Among authors: lu f. Am J Ophthalmol. 2024 Jul;263:23-34. doi: 10.1016/j.ajo.2024.02.010. Epub 2024 Feb 21. Am J Ophthalmol. 2024. PMID: 38395329 Free article. Clinical Trial.

10

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial.

Wang TH, Aung T, Lu DW, George R, Senthil S, Lu F, Odani-Kawabata N, Park KH. Wang TH, et al. Among authors: lu dw, lu f. Clin Ophthalmol. 2024 Jul 16;18:2093-2106. doi: 10.2147/OPTH.S465369. eCollection 2024. Clin Ophthalmol. 2024. PMID: 39051019 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,746 results

Search Page

Filters